Search results for: “clinical trials”
-
Coronavirus and Your Macular Degeneration Care
**Important Update as of 2/5/2021 Since the publishing of these guidelines in March of 2020, information has come to light regarding AMD patients’ risk of more severe illness if they contract COVID-19. Please continue to follow the guidelines below in regards to your eye care, follow the CDC recommended protocols to reduce your risk of…
-
New Proposed Bill Could Drive $1 Billion to Eye Research Over 4 Years
D.C. Financial Analyst, Karen Petrou, and founder of Federal Financial Analytics may have designed a solution to getting big investors behind a stage of research that is so hard to fund, it has been dubbed the “Valley of Death” of research by some. We interviewed Karen to talk about the bill. You can listen to…
-
New Proposed Bill Could Drive $1 Billion to Eye Research Over 4 Years
D.C. Financial Analyst, Karen Petrou, and founder of Federal Financial Analytics may have designed a solution to getting big investors behind a stage of research that is so hard to fund, it has been dubbed the “Valley of Death” of research by some. We interviewed Karen to talk about the bill. You can listen to…
-
Stem Cell Transplantation to Treat Macular Degeneration
Masayo Takahashi, MD, PhDRiken Center for Developmental BiologyLab for Retinal Regeneration Full Transcript Photoreceptors or Rods and cones enable us to see in day or night. Retinal Pigment Epithelial or RPE cells nourish the rods and cones. Without healthy RPE cells the photoreceptor cells are damaged or die. Masayo Takahashi: Once the photo receptor cells…
-
Join AMDF’s Newsletter for Important News about Macular Degeneration
Important Information for Everyone Dealing with AMD! The AMDF Newsletter, In the Spotlight, provides regular interviews, tip sheets, and updates on research, healthy living and managing AMD, all delivered in a useful format: Previous Issues of the AMDF Newsletter are available for$10.00 each ($15.00 Foreign). The Newsletter makes a thoughtful gift too! If you wish to mail your contribution to…
-
Macular Degeneration Treatments
Macular degeneration treatment breakthroughs inspire hope that someday we may see a cure to this disease. Promising treatments, described below, depend upon the stage of disease progression. Dry Macular Degeneration Treatments Nutritional Therapy The treatment for early dry AMD is generally nutritional therapy, with a healthy diet high in antioxidants to support the cells of…
-
Living with Stargardt Disease
Gabriel Travis, MD, Professor of Ophthalmology and Biological ChemistryUCLA School of Medicine Full Transcript Narrator: 11 Year old Meaghan’s parents had never heard of Stargardt and initially thought their daughter only needed glasses. Then they received her diagnosis. Meaghan’s Mom: For us at that point in time it was devastating. It was so difficult to…
-
Stargardt Disease Defined
In rare cases–one in 20,000–macular degeneration is diagnosed in children and teenagers. Of those cases, the most common cause is Stargardt disease, named for Karl Stargardt, a German ophthalmologist who first reported a case in his practice in 1901. Sometimes called Stargardt’s disease, Stargardt affects both eyes and develops sometime between the ages of six and twenty, when kids notice difficulties…
-
What is Macular Degeneration?
Macular Degeneration, also known as Age-related Macular Degeneration (AMD), is the leading cause of irreversible vision loss in adults over 60, affecting nearly 20 million Americans. The risk of developing AMD increases with age. If you are 75 or older, your risk is 1 in 3. There is also a juvenile form of macular degeneration…